tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CSCI Stock Latest News

COSCIENS Biopharma Reports Q1 2025 Results and Strategic Updates
Company AnnouncementsCOSCIENS Biopharma Reports Q1 2025 Results and Strategic Updates
3d ago
6K
CSCI
COSCIENS Biopharma Reports Q1 2025 Financial Results Amid Strategic Shifts
PremiumCompany Announcements
COSCIENS Biopharma Reports Q1 2025 Financial Results Amid Strategic Shifts
3d ago
6K
CSCI
COSCIENS Biopharma Inc. Reports Transformative Year
PremiumCompany Announcements
COSCIENS Biopharma Inc. Reports Transformative Year
10d ago
CSCI
COSCIENS Biopharma Sets Date for Annual Meeting Amid Strategic Shifts
PremiumCompany Announcements
COSCIENS Biopharma Sets Date for Annual Meeting Amid Strategic Shifts
14d ago
6K
CSCI
COSCIENS Biopharma Appoints Anna Biehn as New CEO to Drive Growth in Natural-Based Products
PremiumCompany Announcements
COSCIENS Biopharma Appoints Anna Biehn as New CEO to Drive Growth in Natural-Based Products
1M ago
CSCI
Cosciens Biopharma appoints Biehn as CEO
PremiumThe FlyCosciens Biopharma appoints Biehn as CEO
1M ago
CSCI
COSCIENS Biopharma Reports Revenue Growth and Strategic Repositioning
Premium
Company Announcements
COSCIENS Biopharma Reports Revenue Growth and Strategic Repositioning
1M ago
CSCI
COSCIENS Biopharma Faces Management Cease Trade Order Amid Filing Delays
Premium
Company Announcements
COSCIENS Biopharma Faces Management Cease Trade Order Amid Filing Delays
1M ago
CSCI
COSCIENS Biopharma Faces Potential Delay in Year-End Filings Due to Merger Complexities
PremiumCompany Announcements
COSCIENS Biopharma Faces Potential Delay in Year-End Filings Due to Merger Complexities
2M ago
CSCI
Cosciens Biopharma announces possible delay in filing 2024-end documents
PremiumThe Fly
Cosciens Biopharma announces possible delay in filing 2024-end documents
2M ago
CSCI
COSCIENS Biopharma Advances Avenanthramides to Phase 2a Trial
PremiumCompany Announcements
COSCIENS Biopharma Advances Avenanthramides to Phase 2a Trial
2M ago
CSCI
Cosciens Biopharma announces initiation of Phase 2a study for avenanthramides
PremiumThe Fly
Cosciens Biopharma announces initiation of Phase 2a study for avenanthramides
2M ago
CSCI
COSCIENS Biopharma Focuses on Natural Product Growth
PremiumCompany AnnouncementsCOSCIENS Biopharma Focuses on Natural Product Growth
5M ago
CSCI
Cosciens Biopharma provides update, reiterates pipeline prioritization
Premium
The Fly
Cosciens Biopharma provides update, reiterates pipeline prioritization
5M ago
CSCI
COSCIENS Biopharma Advances Merger and Pipeline
Premium
Company Announcements
COSCIENS Biopharma Advances Merger and Pipeline
6M ago
CSCI
Cosciens Biopharma reports Q3 revenue $1.9M vs $2M last year
PremiumThe Fly
Cosciens Biopharma reports Q3 revenue $1.9M vs $2M last year
6M ago
CSCI
COSCIENS Biopharma Restructures Board After Resignation
PremiumCompany Announcements
COSCIENS Biopharma Restructures Board After Resignation
7M ago
6K
CSCI
Cosciens Biopharma director Carolyn Egbert resigns
PremiumThe Fly
Cosciens Biopharma director Carolyn Egbert resigns
7M ago
CSCI
COSCIENS Biopharma Welcomes New Board Director
PremiumCompany Announcements
COSCIENS Biopharma Welcomes New Board Director
8M ago
6K
CSCI
COSCIENS Biopharma Advances Merger and Seeks New Leadership
PremiumCompany AnnouncementsCOSCIENS Biopharma Advances Merger and Seeks New Leadership
8M ago
CSCI
Cosciens Biopharma provides update on merger integration, succession plans
Premium
The Fly
Cosciens Biopharma provides update on merger integration, succession plans
8M ago
CSCI
Cosciens Biopharma provides update on development projects
Premium
The Fly
Cosciens Biopharma provides update on development projects
8M ago
CSCI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >